Phase III Study of HRS-5635 in Nucleos(t)Ide Analogue-suppressed HBeAg-negative Patients With Chronic Hepatitis B
Clinical trial NCT07606950 · RECRUITING
Trial details
- NCT number
- NCT07606950
- Sponsor
- Fujian Shengdi Pharmaceutical Co., Ltd.
- Status
- RECRUITING
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 2026-07-17
- Primary completion
- 2028-06-01
- Enrollment
- 540
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.